Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to outsmart childhood leukemia with targeted treatments

NCT ID NCT04478006

First seen Feb 03, 2026 · Last updated May 19, 2026 · Updated 19 times

Summary

This study is looking at the genes and drug responses of children with leukemia to find better, less toxic treatments. Researchers will collect samples from 300 children with different types of leukemia to understand why some cases relapse. The goal is to use this information to develop safer, targeted therapies for high-risk patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hong Kong Children Hospital

    RECRUITING

    Hong Kong, Hksar, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.